HCA Healthcare (HCA)
(Delayed Data from NYSE)
$341.26 USD
+3.82 (1.13%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $341.34 +0.08 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$341.26 USD
+3.82 (1.13%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $341.34 +0.08 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Zacks News
Here's Why HCA Healthcare (HCA) Fell More Than Broader Market
by Zacks Equity Research
HCA Healthcare (HCA) concluded the recent trading session at $279.33, signifying a -0.77% move from its prior day's close.
HCA Healthcare (HCA) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the latest trading session, HCA Healthcare (HCA) closed at $275.32, marking a +1.71% move from the previous day.
Reasons to Retain HCA Healthcare (HCA) Stock in Your Portfolio
by Zacks Equity Research
HCA Healthcare's (HCA) improving top line, acquisition initiatives and a robust growth outlook poise the company well for growth.
HCA Healthcare (HCA) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the most recent trading session, HCA Healthcare (HCA) closed at $269.18, indicating a +0.75% shift from the previous trading day.
HCA Healthcare, Inc. (HCA) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Bulls Look Optimistic About HCA (HCA): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks Industry Outlook Highlights HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems
by Zacks Equity Research
HCA Healthcare, Universal Health Services, Tenet Healthcare, Acadia Healthcare Company and Community Health Systems are part of the Zacks Industry Outlook article.
5 Hospital Stocks to Watch Amid Promising Industry Trends
by Kaibalya Pravo Dey
Rising patient volumes and technological advancements for the Zacks Medical-Hospital industry players are major positives. HCA, UHS, THC, ACHC and CYH are poised to gain from improving operating efficiency.
HCA Healthcare (HCA) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
HCA Healthcare (HCA) closed the most recent trading day at $262.02, moving +1.74% from the previous trading session.
HCA Healthcare's (HCA) Houston Affiliate Acquires 11 EDs
by Zacks Equity Research
The deal helps HCA Healthcare (HCA) boost its freestanding EDs in the Houston region to 26, supplementing its existing hospital-based emergency rooms.
HCA Healthcare (HCA) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
HCA Healthcare (HCA) concluded the recent trading session at $257.14, signifying a +1.89% move from its prior day's close.
Investors Heavily Search HCA Healthcare, Inc. (HCA): Here is What You Need to Know
by Zacks Equity Research
HCA (HCA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Wall Street Analysts Think HCA (HCA) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for HCA (HCA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Universal Health Services (UHS) Up 11.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is HCA (HCA) Up 12.3% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HCA Healthcare (HCA) Unveils Ambitious 5-Year Growth Targets
by Zacks Equity Research
Over the five-year horizon, HCA Healthcare (HCA) anticipates substantial 8-12% annual growth in earnings per share.
3 Sector ETFs & Stocks to Gain Despite Soft Jobs Data
by Sanghamitra Saha
The U.S. economy added 150,000 jobs in October 2023, below market forecasts of 180,000.
Here is What to Know Beyond Why HCA Healthcare, Inc. (HCA) is a Trending Stock
by Zacks Equity Research
HCA (HCA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Zacks Analyst Blog Highlights Costco Wholesale, Pfizer, IBM, NextEra Energy and HCA Healthcare
by Zacks Equity Research
Costco Wholesale, Pfizer, IBM, NextEra Energy and HCA Healthcare are part of the Zacks top Analyst Blog.
Top Research Reports for Costco, Pfizer & IBM
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corp. (COST), Pfizer Inc. (PFE) and IBM Corp. (IBM).
Community Health (CYH) Stock Down 1.7% Since Q3 Earnings Release
by Zacks Equity Research
Community Health (CYH) expects net operating revenues in the range of $12,400-$12,500 million for 2023.
HCA Healthcare's (HCA) Q3 Earnings Miss on High Expense Level
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 results were hurt by an increase in salaries and benefits expenses. Management presently estimates 2023 EPS to be within $17.80-$18.50, compared with the prior-view of $17.70-$18.90 per share.
HCA (HCA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
HCA Healthcare (HCA) Lags Q3 Earnings Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of -1.51% and 2.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Yield Curve Rapidly Steepens in First Test of Bear Steepening In 40 Years
by Mayur Thaker
Risks continue to rise as the key equity index loses medium term moving averages